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Abstract
The Edinburgh Postnatal Depression Scale (EPDS) is the instrument most used worldwide for
screening of Post-Partum Depression (PPD). The SRQ20 questionnaire has been largely used for
screening of minor psychiatric disorders. This study aimed to compare the accuracy of the two
instruments in screening for PPD. At the third-month follow-up home visit to infants of the 2004
Pelotas Birth Cohort, Southern Brazil, a sub-sample of 378 mothers was selected. Among other
questions, EPDS and SRQ20 were applied by trained fieldworkers. Up to 15 days later, a mental
health professional re-interviewed the mother (the gold standard interview). Sensitivity and
specificity of each cutoff point were calculated for EPDS and SRQ20 and the results were plotted
at a ROC curve. The areas under both curves were compared. Highest sensitivity and specificity
cutoff were observed for EPDS ≥ 10 (sensitivity 82.7%, 95%CI 74.0 – 89.4; specificity 65.3%, 95%CI
59.4 – 71.0) and for SRQ20 ≥ 6 (sensitivity 70.5%, 95%CI 60.8 – 79.0%; specificity 75.5%, 95%CI
70.0 – 80.5%). Shape of ROC curves and areas under both curves were virtually identical
(respectively, 0.8401 ± 0.02 for EPDS and 0.8402 ± 0.02 for SRQ20; p = 0.9). In conclusion SRQ20
showed to be as valid as EPDS as a screening tool for PPD at third month after delivery.
Background
Postpartum depression (PPD) can lead to maternal
reduced interaction and irritability misdirected at the
child [1]. PPD can impair adequate infant care and
increase the risk for infant cognitive and emotional delay
[2]. Some authors have recognized PPD as a public health
problem and recommended the systematic screening of
the condition, in both antenatal and postnatal periods
[3,4]. In clinical settings, identification of PPD can be
improved by increasing awareness and skills of health
professionals in recognizing maternal depressive symp-
toms or by screening for PPD through the use of specific
questionnaires [5].
The Edinburgh Postnatal Depression Scale (EPDS) [6] and
the Self-Reporting Questionnaire 20 items (SRQ20) [7,8]
are largely used in mental health research. The EPDS is the
most widely accepted screening scale used worldwide in
the perinatal period [9]. The SRQ20 was developed by the
World Health Organization to screen for common mental
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disorders (depression and anxiety) in primary health care.
Both questionnaires are not substitute for, or equivalent
to, a clinical diagnosis. They indicate probable cases of
mental disorder by identifying individuals who need fur-
ther evaluation. Both tests are not of exclusive use among
specific population groups. As sated by the authors, EPDS
may be used for screening and diagnosis of depression at
community level, indistinctly among men and women
[6]. The SRQ20 questionnaire may be applied to identify
in risk individuals, independently of sex and childbearing
status.
This study was planned to compare the performance of
SRQ20 and EPDS in screening for PPD in a sample of
mothers from the 2004 Pelotas Birth Cohort, three
months after delivery, having as gold standard an inter-
view conducted by mental health professionals.
At age three months, all the infants from the cohort [10],
a population-based study which included all children
born in the city's five hospitals, were visited at home. At
this occasion their mothers were interviewed and, among
other questions the EPDS (Table 1) and the SRQ20 ques-
tionnaires were administered. The EPDS performance as a
screening and diagnostic tool for post-partum depression
was tested and the results are available in another publica-
tion [11].
For the purpose of the present study, mothers whose
babies reached age three months between 1 January and
31 March 2005 (born, therefore, between 1 October and
31 December 2004) were included. The majority of the
interviews were strictly paid in the time frame between
one week before and one week after the day in which the
infant completed his/her third month of life (between
weeks 12 and 14 after birth, in average at week 13.1 (SD =
0.6). Only women who gave birth to singletons were eli-
gible.
Questions of the two instruments were posed to mothers
by a trained interviewer, as a single block and in the same
order as in the original instrument. The decision to pose
the questions to mothers verbally instead of self-adminis-
tered was due to the high proportion of mothers with little
schooling. The administration of SRQ20 and EPDS as an
interview is accepted by the instrument's authors and has
already been used previously [7,8].
To the present analysis, all mothers scoring 9 points or
more in the EPDS were selected. Then, a systematic sam-
ple of mothers scoring < 9 was obtained by recruiting
every fourth mother in this condition. All the selected
mothers underwent a diagnostic interview (gold stand-
ard).
For the diagnostic interview (gold standard), mothers
were re-visited at home by a mental health professional
(psychiatrist, psychologist, or psychiatry resident), previ-
ously trained for the administration of a semi-structured
Table 1: Edinburgh Test (Portuguese version)
Marque a resposta que melhor reflete como você tem se sentido nos 
últimos 7 dias:
1. Eu tenho sido capaz de rir e achar graça das coisas.
() Como eu sempre fiz.
() Não tanto quanto antes.
() Sem dúvida, menos que antes.
() De jeito nenhum.
2. Eu tenho pensado no futuro com alegria.
() Sim, como de costume.
() Um pouco menos que de costume.
() Muito menos que de costume.
() Praticamente não.
3. Eu tenho me culpado sem razão quando as coisas dão errado.
() Não, de jeito nenhum.
() Raramente.
() Sim, às vezes.
() Sim, muito freqüentemente.
4. Eu tenho ficado ansiosa ou preocupada sem uma boa razão.
() Sim, muito seguido.
() Sim, às vezes.
() De vez em quando.
() Não, de jeito nenhum.
5. Eu tenho me sentido assustada ou em pânico sem um bom motivo.
() Sim, muito seguido.
() Sim, às vezes.
() Raramente.
() Não, de jeito nenhum.
6. Eu tenho me sentido sobrecarregada pelas tarefas e 
acontecimentos do meu dia-a-dia.
() Sim. Na maioria das vezes eu não consigo lidar bem com eles.
() Sim. Algumas vezes não consigo lidar bem como antes.
() Não. Na maioria das vezes consigo lidar bem com eles.
() Não. Eu consigo lidar com eles tão bem quanto antes.
7. Eu tenho me sentido tão infeliz que eu tenho tido dificuldade de 
dormir.
() Sim, na maioria das vezes.
() Sim, algumas vezes.
() Raramente.
() Não, nenhuma vez.
8. Eu tenho me sentido triste ou muito mal.
() Sim, na maioria das vezes.
() Sim, muitas vezes.
() Raramente.
() Não, de jeito nenhum.
9. Eu tenho me sentido tão triste que tenho chorado.
() Sim, a maior parte do tempo.
() Sim, muitas vezes.
() Só de vez em quando.
() Não, nunca.
10. Eu tenho pensado em fazer alguma coisa contra mim mesma.
() Sim, muitas vezes.
() Às vezes.
() Raramente.
() Nunca.Clinical Practice and Epidemiology in Mental Health 2007, 3:18 http://www.cpementalhealth.com/content/3/1/18
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interview, which was based on ICD-10 diagnostic criteria
[12] to explored the presence of depressed mood most of
the days of the last two consecutive weeks. It was a stand-
ardized semi-structured questionnaire containing major
obligatory symptoms, accessory symptoms, as well as cri-
teria for differential diagnosis to be fulfilled during the
interview. For standardization purposes, interviewers
were trained before data collection. Training included the
reading and discussion of the instrument and role-playing
sections headed by a Senior psychiatrist, who also
reviewed and codified all records from interview with the
mothers. The diagnostic interview was aimed at detecting
the current or recent (last 15 days) depressive episodes.
According to the result of this interview, mothers were
classified as 'normal' or 'positive,' the latter including
those with mild, moderate or severe episodes of depres-
sion. Mental health professionals were blinded as to the
score obtained by mothers using EPDS or SRQ20. Average
time interval between EPDS/SRQ20 application and the
gold standard interview was 18.3 (SD = 9.6) days (median
= 16 days; range = 5 – 60 days).
For each EPDS and SRQ20 cutoff point, sensitivity (pro-
portion of depressed mothers according to ICD-10 criteria
that were correctly identified) and specificity (proportion
of non-depressed mothers correctly identified as such)
were calculated. The cutoff point showing simultaneously
the highest sensitivity and specificity was determined
using a Receiver Operator Characteristic (ROC) curve for
both, the EPDS and the SRQ20. Plotted in the same
graphic, the ROC curves were used to compare accuracy of
SRQ20 and EPDS as estimated through the size of the area
under each curve. Stata 9.1 software was used for all anal-
yses.
The research protocol was approved by the Research Eth-
ics Committee of the University of Pelotas Medical School
and written maternal consent was obtained before the
interviews.
A total of 965 singleinfants were born between 1 October
and 31 December 2004. There were 79 losses and refusals
(8.2%). Of the 886 mothers for whom the SRQ20 and
EPDS were administered, 219 presented EPDS ≥ 9 and
667 EPDS < 9. As a result 378 responded also to the diag-
nostic interview (219 with EPDS ≥ 9 and 159 with EPDS
< 9). According to the gold standard, 105 mothers pre-
sented mild, moderate, or severe episodes of depression,
and the remaining 273 were classified as normal.
The wide majority of the mothers (83.6%) came from
families with monthly family income of up to three min-
imum wages. About 67% were aged 20–34 years, and over
one-fifth (22.2%) were adolescents. Only two mothers
had never attended school, whereas 15% had between
one and four, and about 40%, nine or more years of
schooling. The majority of women were white (70.9%),
and 81.2% lived with a husband or partner. A little more
than one-third of mothers (38.4%) worked outside home
during pregnancy. The majority of pregnancies were
unplanned (67.2%). The prevalence of babies with low
birth weight (< 2,500 grams) and preterm births (< 37 ges-
tational weeks) (10,8% and 16.4%, respectively), as well
as the frequency of all maternal characteristics examined
in the sample, with the exception of smoking during preg-
nancy, were statistically similar to those of the 2004
cohort as a whole (n = 4,287 alive and singleton births).
The prevalence of maternal smoking was higher in the
sample (33.6% versus 25.1%; p < 0.001).
Correlation coefficient between EPDS and SRQ20 as
regard to true positive results was 0.7251. The two tests
fully agreed for 295 mothers. Among 83 mothers the
observed disagreement was for 44 who were positive to
the EPDS and negative to the SRQ20, and the contrary for
the remaining 39 mothers. Kappa statistics of the agree-
ment between the two tests was 56% (95%CI 48–64%).
As shown in Table 2 and Figure 1, for EPDS the cutoff
point ≥ 10 was the best for screening PPD among that
population with sensitivity 82.7% (74.0% – 89.4%) and
specificity 65.3% (59.4% – 71.0%). For SRQ20 the corre-
spondent best cutoff was ≥ 6 with sensitivity 70.5%
(95%CI 60.8 – 79.0%) and specificity 75.5% (95%CI
70.0 – 80.5%). At those cutoffs, accuracy of both instru-
ments was similar, respectively, 70.1% for EPDS and
74.1% for SRQ20. Figure 1 also shows that shape of ROC
curves and areas under both curves were virtually identi-
cal, respectively, 0.8401 ± 0.02 for EPDS and 0.8402 ±
0.02 for SRQ20 (p = 0.9).
A potential source of criticism for the current analysis
refers to the time after birth in which the screening was
conducted. However, there is an incomplete knowledge
regarding the natural history of PPD: while for the Diag-
nostic and Statistical Manual of Mental Disorders, 4th ed.
(DSM-IV) PPD has its onset within four weeks post-par-
tum, others define onset up to the three months post-par-
tum [13,14]. Therefore, the ideal timeframe for screening
has not yet been established [15]. Most PPD research has
used the second and third post-partum months for screen-
ing [5]. Furthermore, most instruments used to screen
PPD were tested and showed to be valid and reliable when
applied in the second and third post-partum months [16].
A recent meta-analysis reviewing articles printed in Eng-
lish and published up to December 2004, identified eight
self-report questionnaires currently used for assessing
depressive symptoms within the first year postpartum
[13]. The EPDS, but not the SRQ20, was among them. The
present study showed that SRQ20 and EPDS are very sim-Clinical Practice and Epidemiology in Mental Health 2007, 3:18 http://www.cpementalhealth.com/content/3/1/18
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ilar in performance to screen for PPD when assessed
against the psychiatric interview taken as the gold stand-
ard. A previous study had already described a good agree-
ment rate between EPDS and SRQ20, with a Kappa
statistics of 0.75 [17]. Such findings support the validity of
SRQ20 as a screening tool for PPD.
It should be noted that the highest sensitivity and specifi-
city for SRQ20 as a screening tool for Brazilian women in
general population was obtained with a cutoff of ≥ 8 [18].
For PPD, the corresponding SRQ20 cutoff point was
lower, ≥ 6.
Characteristics regarding area of application and type of
administration are very similar for EPDS and SRQ20. Both
were developed for use in clinical and research settings
and have the advantage of being suitable for use by lay
interviewers in a face-to-face interview. Although EPDS
has a smaller number of items than the SRQ20, the last
can typically be applied by trained interviewers in a ten
minute time [8].
The results of this study may be relevant for primary
health care services and for future research. As PPD gains
growing recognition as a public health concern and evi-
dence of benefit of early treatment accumulates, the
number of studies to identify the group of mothers in
higher risk of PPD will increase. Due to its large use and
the evidence of its adequate accuracy, the use of the
SRQ20 as a screening tool for detecting PPD should also
be considered.
Table 2: Sensitivity, specificity of a Brazilian version of EPDS and of SRQ20.
EPDS SRQ20
Cutoff points Sensitivity (95%CI) Specificity (95%CI) Cutoff points Sensitivity (95%CI) Specificity (95%CI)
≥3 99.0 (94.8 – 100) 16.4 (12.2 – 21.4) ≥1 100 (96.5 – 100) 10.9 (7.5 – 15.3)
≥4 98.1 (93.3 – 99.8) 23.7 (18.8 – 29.2) ≥2 99.0 (94.8 – 100) 20.4 (15.8 – 25.7)
≥5 97.1 (91.9 – 99.4) 33.6 (28.0 – 39.5) ≥3 99.0 (94.8 – 100) 33.9 (28.4 – 39.9)
≥6 96.2 (90.5 – 99.0) 39.8 (33.9 – 45.8) ≥4 96.2 (90.5 – 99.0) 43.4 (37.5 – 49.5)
≥7 96.2 (90.5 – 99.0) 45.6 (39.6 – 51.7) ≥5 90.5 (83.2 – 95.3) 55.1 (49.0 – 61.1)
≥8 93.3 (86.7 – 97.3) 50.4 (44.3 – 56.4) ≥6 84.8 (76.4 – 91.0) 67.9 (62.0 – 73.4)
≥9 91.3 (84.2 – 96.0) 54.7 (48.6 – 60.7) ≥7 70.5 (60.8 – 79.0) 75.5 (70.0 – 80.5)
≥10 82.7 (74.0 – 89.4) 65.3 (59.4 – 71.0) ≥8 64.8 (54.8 – 73.8) 81.4 (76.3 – 85.8)
≥11 74.0 (64.5 – 82.1) 77.4 (72.0 – 82.2) ≥9 62.9 (52.9 – 72.1) 86.5 (81.9 – 90.3)
≥12 65.4 (55.4 – 74.4) 82.1 (77.1 – 86.5) ≥10 54.3 (44.3 – 60.0) 92.0 (88.1 – 94.9)
≥13 59.6 (49.5 – 69.1) 88.3 (83.9 – 91.9) ≥11 44.8 (35.0 – 54.8) 93.4 (89.8 – 96.1)
≥14 50.0 (40.0 – 60.0) 92.3 (88.5 – 95.2) ≥12 28.6 (20.2 – 38.2) 96.4 (93.4 – 98.2)
≥15 40.4 (30.9 – 50.5) 94.2 (90.7 – 96.6) ≥13 22.9 (15.2 – 32.1) 98.2 (95.8 – 99.4)
≥16 36.5 (27.3 – 46.6) 96.4 (93.4 – 98.2) ≥14 20.0 (12.8 – 28.9) 99.3 (97.4 – 99.0)
≥15 14.3 (8.2 – 22.5) 99.6 (98.0 – 100)
≥16 6.7 (2.7 – 13.3) 99.6 (98.0 – 100)
ROC curves for the SRQ20 and the EPDS for Post Partum  Depression Figure 1
ROC curves for the SRQ20 and the EPDS for Post Partum 
Depression. Solid line: EPDS. Broken line: SRQ20
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